Mesa Laboratories (MLAB) News Today $95.82 +2.83 (+3.04%) Closing price 04:00 PM EasternExtended Trading$95.66 -0.16 (-0.17%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MLAB Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Mesa Laboratories, Inc. (NASDAQ:MLAB) SVP Brian David Archbold Sells 472 SharesJune 19 at 8:01 AM | insidertrades.comInsider Selling: Mesa Laboratories, Inc. (NASDAQ:MLAB) SVP Sells 472 Shares of StockMesa Laboratories, Inc. (NASDAQ:MLAB - Get Free Report) SVP Brian David Archbold sold 472 shares of Mesa Laboratories stock in a transaction that occurred on Monday, June 16th. The stock was sold at an average price of $97.12, for a total transaction of $45,840.64. Following the transaction, the senior vice president now directly owns 558 shares in the company, valued at $54,192.96. The trade was a 45.83% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.June 18 at 2:50 PM | marketbeat.comGary M. Owens Sells 1,939 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) StockMesa Laboratories, Inc. (NASDAQ:MLAB - Get Free Report) CEO Gary M. Owens sold 1,939 shares of the business's stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $97.12, for a total value of $188,315.68. Following the transaction, the chief executive officer now owns 45,824 shares in the company, valued at approximately $4,450,426.88. This represents a 4.06% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.June 18 at 2:50 PM | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Sees Large Volume Increase - Still a Buy?Mesa Laboratories (NASDAQ:MLAB) Sees Unusually-High Trading Volume - Here's What HappenedJune 18 at 2:46 PM | marketbeat.comInsider Selling: Mesa Laboratories, Inc. (NASDAQ:MLAB) CFO Sells 642 Shares of StockMesa Laboratories, Inc. (NASDAQ:MLAB - Get Free Report) CFO John Sakys sold 642 shares of Mesa Laboratories stock in a transaction dated Monday, June 16th. The shares were sold at an average price of $97.12, for a total transaction of $62,351.04. Following the completion of the sale, the chief financial officer now owns 12,865 shares in the company, valued at approximately $1,249,448.80. This trade represents a 4.75% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.June 18 at 11:23 AM | marketbeat.comGAMMA Investing LLC Increases Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)GAMMA Investing LLC grew its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 14,805.8% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 18,036 shares of the medical instruments supplier's stock after buying an additional 17,915 shares durJune 14, 2025 | marketbeat.commesa laboratories announces change in auditing firm after mergerJune 8, 2025 | investing.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.54 Million Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 91.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 19,292 shares of the medical instruments supplier'sJune 7, 2025 | marketbeat.comWellington Management Group LLP Makes New Investment in Mesa Laboratories, Inc. (NASDAQ:MLAB)Wellington Management Group LLP purchased a new stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 14,314 shares of the medical instruments suppJune 6, 2025 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Sees Unusually-High Trading Volume - Should You Buy?Mesa Laboratories (NASDAQ:MLAB) Sees Unusually-High Trading Volume - What's Next?June 5, 2025 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Downgraded to Buy Rating by Wall Street ZenWall Street Zen cut Mesa Laboratories from a "strong-buy" rating to a "buy" rating in a research report on Friday.June 1, 2025 | marketbeat.comWells Fargo & Company Lowers Mesa Laboratories (NASDAQ:MLAB) Price Target to $100.00Wells Fargo & Company dropped their price target on shares of Mesa Laboratories from $120.00 to $100.00 and set an "underweight" rating on the stock in a research note on Friday.May 31, 2025 | marketbeat.comKings Path Partners LLC Decreases Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)Kings Path Partners LLC lessened its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 38.6% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,161 shares of the medical instruments supplier's stock after sellMay 31, 2025 | marketbeat.comCitadel Advisors LLC Trims Stock Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)Citadel Advisors LLC decreased its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 36.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,817 shares of the medical instruments supplier'sMay 30, 2025 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Shares Gap Down Following Weak EarningsMesa Laboratories (NASDAQ:MLAB) Shares Gap Down After Earnings MissMay 29, 2025 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Releases Quarterly Earnings Results, Misses Expectations By $1.10 EPSMesa Laboratories (NASDAQ:MLAB - Get Free Report) released its quarterly earnings results on Wednesday. The medical instruments supplier reported $1.65 EPS for the quarter, missing the consensus estimate of $2.75 by ($1.10). Mesa Laboratories had a negative net margin of 104.92% and a positive return on equity of 30.23%.May 29, 2025 | marketbeat.comMesa Laboratories, Inc.: Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 ResultsMay 29, 2025 | finanznachrichten.deMesa Labs Stock Slides on Unexpected 4Q LossMay 29, 2025 | marketwatch.comMesa Labs: Fiscal Q4 Earnings SnapshotMay 29, 2025 | washingtonpost.comMesa Laboratories (MLAB) Projected to Post Quarterly Earnings on WednesdayMesa Laboratories (NASDAQ:MLAB) will be releasing its Q4 2025 earnings before the market opens on Wednesday, June 4. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-6-4-mesa-laboratories-inc-stock/)May 29, 2025 | marketbeat.comMesa Laboratories Non-GAAP EPS of $2.25 beats by $0.18, revenue of $62.14M beats by $0.24MMay 28, 2025 | seekingalpha.comMesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 ResultsMay 28, 2025 | globenewswire.comBank of America Corp DE Has $9.03 Million Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB)Bank of America Corp DE lifted its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 27.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 68,474 shares of the medical instruments supplier'sMay 26, 2025 | marketbeat.comJanus Henderson Group PLC Raises Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB)Janus Henderson Group PLC increased its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 10.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 86,286 shares of the medical instruments supplier's stock after acquiring an additional 8,0May 19, 2025 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Stake Raised by Ameriprise Financial Inc.Ameriprise Financial Inc. increased its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 191.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 151,862 shares of the medical iMay 18, 2025 | marketbeat.comMeros Investment Management LP Acquires 7,023 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)Meros Investment Management LP raised its position in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 21.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 40,263 shares of the medical instruments supplier's stockMay 15, 2025 | marketbeat.comJane Street Group LLC Increases Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)Jane Street Group LLC boosted its position in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 1,390.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 34,399 shares of the medical instruments suppMay 13, 2025 | marketbeat.comDimensional Fund Advisors LP Decreases Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)Dimensional Fund Advisors LP decreased its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 7.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 113,850 shares of the medical instruments suppMay 11, 2025 | marketbeat.comMesa Laboratories Stock Dividends | NASDAQ:MLAB | BenzingaMay 6, 2025 | benzinga.comMarshall Wace LLP Cuts Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)Marshall Wace LLP reduced its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 59.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,476 shares of the medical instruments supplier'May 6, 2025 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Sees Significant Growth in Short InterestMesa Laboratories, Inc. (NASDAQ:MLAB - Get Free Report) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 224,300 shares, an increase of 20.1% from the March 31st total of 186,700 shares. Based on an average daily trading volume, of 44,100 shares, the short-interest ratio is currently 5.1 days. Currently, 4.3% of the company's stock are sold short.May 5, 2025 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Renaissance Technologies LLCRenaissance Technologies LLC lessened its position in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 44.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,500 shares of the medical instrumentsMay 3, 2025 | marketbeat.comJPMorgan Chase & Co. Sells 3,403 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)JPMorgan Chase & Co. cut its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 40.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 5,003 shares of the medical instruments supplier's stock after selling 3,403 sharMay 2, 2025 | marketbeat.com7,417 Shares in Mesa Laboratories, Inc. (NASDAQ:MLAB) Purchased by Herald Investment Management LtdHerald Investment Management Ltd bought a new stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 7,417 shares of the medical instruments supplier's stock, valued aApril 20, 2025 | marketbeat.comFranklin Resources Inc. Decreases Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)Franklin Resources Inc. reduced its position in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 48.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,291 shares of the medical instruments supplier's stoApril 20, 2025 | marketbeat.comRaymond James Financial Inc. Acquires Shares of 247,795 Mesa Laboratories, Inc. (NASDAQ:MLAB)Raymond James Financial Inc. bought a new position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 247,795 shares of tApril 19, 2025 | marketbeat.comWellington Management Group LLP Invests $1.89 Million in Mesa Laboratories, Inc. (NASDAQ:MLAB)Wellington Management Group LLP bought a new position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 14,314 shares of the medical instrumentApril 15, 2025 | marketbeat.comVanguard Group Inc. Acquires 5,274 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)Vanguard Group Inc. lifted its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 1.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 382,856 shares of the medical instruments suppApril 14, 2025 | marketbeat.comKennedy Capital Management LLC Has $9.84 Million Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB)Kennedy Capital Management LLC boosted its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 13.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 74,606 shares of the medicApril 13, 2025 | marketbeat.comAmerican Century Companies Inc. Purchases 4,698 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)American Century Companies Inc. grew its position in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 99.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,444 shares of the medical instrumentsApril 13, 2025 | marketbeat.comExodusPoint Capital Management LP Purchases 7,167 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)ExodusPoint Capital Management LP lifted its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 283.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,692 shares of thApril 12, 2025 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Ranger Investment Management L.P.Ranger Investment Management L.P. lessened its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 1.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 233,555 shares of the medical insApril 11, 2025 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Shares Acquired by Sei Investments Co.Sei Investments Co. raised its position in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 246.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,411 shares of the medical instruments supplier's stoApril 10, 2025 | marketbeat.comMesa Laboratories, Inc. Announces Quarterly Dividend of $0.16 (NASDAQ:MLAB)Mesa Laboratories, Inc. (NASDAQ:MLAB) declared a quarterly dividend on Monday, April 7th. Investors of record on Friday, May 30th will be paid a dividend of 0.16 per share by the medical instruments supplier on Monday, June 16th. This represents a $0.64 annualized dividend and a yield of 0.59%.April 9, 2025 | marketbeat.comMESA LABS DECLARES QUARTERLY DIVIDENDApril 7, 2025 | globenewswire.comMesa Laboratories: Green Shoots EmergeApril 3, 2025 | seekingalpha.comGary M. Owens Sells 21,000 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) StockMesa Laboratories, Inc. (NASDAQ:MLAB - Get Free Report) CEO Gary M. Owens sold 21,000 shares of the company's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $123.91, for a total value of $2,602,110.00. Following the sale, the chief executive officer now directly owns 43,337 shares of the company's stock, valued at approximately $5,369,887.67. This represents a 32.64 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.March 25, 2025 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Boston PartnersBoston Partners trimmed its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 44.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,627 shares of the medical instruments supplier's stock after selling 3,726 shares durMarch 23, 2025 | marketbeat.comVictory Capital Management Inc. Sells 5,165 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)Victory Capital Management Inc. decreased its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 36.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,836 shares of the medicaMarch 20, 2025 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Royce & Associates LPRoyce & Associates LP decreased its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 17.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 287,207 shares of the medical instruments sMarch 17, 2025 | marketbeat.com Get Mesa Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address MLAB Media Mentions By Week MLAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MLAB News Sentiment▼0.530.68▲Average Medical News Sentiment MLAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MLAB Articles This Week▼92▲MLAB Articles Average Week Get Mesa Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FARO News DAKT News VPG News COHR News BMI News ITRI News CGNX News OSIS News SENS News HURC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MLAB) was last updated on 6/20/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Biggest Story of My Decade-Long Career in Silicon ValleySteve Jobs' Lost 'Product' Could Save Tesla On July 21st, a revolutionary announcement could transform Tesl...InvestorPlace | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesa Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesa Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MLAB Stock Free MLAB Stock Alerts